ESR1 and breast carcinoma: In vitro, tamoxifen acts as a partial estrogen antagonist, by antagonizing the estrogen regulation of the transcription of most ER-regulated genes and inhibiting growth of estrogen receptor-dependent breast cancer cells4–6.